Kintsugi
Berkeley · Founded 2019
About Kintsugi
Kintsugi is developing novel voice biomarker software to detect signs of depression and anxiety from short clips of free form speech. Awarded multiple distinctions for AI technology and recently named one of Forbes’ Top 50 AI companies to watch in 2022, Kintsugi helps to close mental health care gaps across risk-bearing health systems, ultimately saving time and lives.
Company Facts
- Founded: 2019
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $30.9M
- Funding stage: Early Stage Venture
- Last round: Series A (Feb 2022)
- Website: https://kintsugihealth.com
- Phone: 310-598-1553
Industries & Categories
Artificial Intelligence (AI), Biotechnology, Health Care, Health Diagnostics, Machine Learning
Social Profiles
Canonical: https://fsome.com/organization/kintsugi-112135 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.